TAKASAGO INTERNATIONAL CORP

Overview

TAKASAGO INTERNATIONAL CORP is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering RUTHENIUM COMPLEX.

API / Drug Master Files

TAKASAGO INTERNATIONAL CORP holds 1 active (15 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RUTHENIUM COMPLEXActive2004-05-24
• RHAInactive2014-02-18
• RU-COMPLEX SOLUTIONInactive2007-03-23
• D-THREO-RITALINIC ACIDInactive2005-07-18
• STERILE FINISHED PRODUCTS AND STERILE PROCESSING OPERATIONS AT THE VIALE ROSSINI PLANT IN MILANO, ITALYInactive2003-08-18
• STERILE FINISHED PRODUCTS AND STERILE PROCESSING OPERATIONS LOCATED IN AMEEPET AND DUNDIGAL, INDIAInactive2003-02-10
• [2R-[2A,5A,6A(RInactive1998-07-06
• MANUFACTURING SITE, FACILTIES, PERSONNEL AND OPERATIONAL PROCEDURES IN SHIZUOKA PREFECTURE, JAPANInactive1998-07-06
• (R)-4-MERCAPTOPYRROLIDIN-2-ONE, OR (R)-MPDInactive1997-01-06
• A-87172.0Inactive1994-12-29
• MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERTATING PROCEDURES IN SHIZUOKA, JAPAN.Inactive1994-12-29
• MANUFACTURING SITE, FACILITIES, OPERATING PROCEDURES AND PERSONNEL IN SHIZUOKA PREFECTURE, JAPANInactive1994-08-06
• A88820.605Inactive1994-08-06
• STERILE FINISHED PRODUCTS AND STERILE PROCESSING OPERATIONS LOCATED IN CAGUAS, PUERTO RICOInactive1993-04-08
• MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN IWATA, JAPAN.Inactive1993-04-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to TAKASAGO INTERNATIONAL CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.